Pure Global AI
Disease / condition

Neoplasms clinical trials

Free access to 482 studies10+ countriesUpdated daily54 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
482
Total trials
10+
Countries
10+
Sponsors
54
Recruiting
By phase
Phase 1287
N/A112
Phase 233
Early Phase 120
Phase 312
By status
Completed309
Recruiting54
Terminated45
Not yet recruit...27
Unknown24
Top countries
United States of America141
China30
Japan27
France14
Netherlands10
Top sponsors
Boehringer Ingelhe...51
Bayer43
Hoffmann-La Roche35
GlaxoSmithKline35
Pfizer19
Recent trials
Latest clinical trials for Neoplasms
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)
GlaxoSmithKline · South Korea,Spain,United States of America
NCT06322693Recruiting
Phase
Phase 1
Safety and Efficacy of Intravenous IDOV-SAFETM in Patients With Advanced Solid Tumors
Cancer Institute and Hospital,... · China
NCT06346041Recruiting
Phase
Phase 1
PET Imaging of 68Ga-Her2-affibody in Tumors With High Her2 Expression
Peking University First Hospit... · China
NCT06289517Not yet recr...
ACS Community Access to Resources Education and Support
American Cancer Society, Inc. · United States of America
NCT06285929Enrolling by...
Determinants of Physical Activity Level in Pediatric Oncological Patients Treated With Cardiotoxic Therapy - a Study Protocol
Medical University of Warsaw
NCT06256068Not yet recr...
BIO-CHECKPOINT 0 Biomarkers to Identify Oncology Patients on ICPI at Greater Risk of irAE
Portsmouth Hospitals NHS Trust · United Kingdom
NCT06247865Not yet recr...
Personalized Live-remote Exercise Training for Cancer Survivors
UMC Utrecht · Netherlands
NCT06270628Not yet recr...
A Prospective, Randomized Trial Assessing the Feasibility of an Advance Care Planning Intervention
Institut de cancérologie Stras... · France
NCT06149312Not yet recr...
18F-FAPI-RGD PET/CT in Various Tumor Types
Sichuan Provincial People's Ho... · China
NCT06094530Recruiting
A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in Participants With Solid Tumors
GlaxoSmithKline · Canada,United States of America
NCT06077877Recruiting
Phase
Phase 1
Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung Cancer
GlaxoSmithKline · Australia,Canada,Germany,Netherlands,Sweden,United States of America
NCT06048705Terminated
Phase
Phase 1
Evaluation and Implementation Preparation of a Proactive Palliative Care Model (ENABLE-SG)
National Cancer Centre, Singap... · Singapore
NCT06044441Not yet recr...
Individual Food Preferences for the Mediterranean Diet in Cancer Patients
Centre Antoine Lacassagne · France
NCT06058312Recruiting
Noninvasive Internal Jugular Venous Oximetry
National Taiwan University Hos... · Taiwan
NCT06004466Recruiting
Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma
GlaxoSmithKline · Canada,Netherlands,United Kingdom,United States of America
NCT05993299Recruitment ...
Phase
Phase 2
Untitled Trial
jRCT1030230268Recruiting
Exercise For Fighting Oncology Repercussions After Treatment
Universitat Pompeu Fabra
NCT05980325Not yet recr...
Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma
GlaxoSmithKline · Australia,Canada,Germany,Netherlands,Sweden,United States of America
NCT05943990Terminated
Phase
Phase 1
68Ga-P3 PET/CT Imaging in Prostate
Peking University First Hospit... · China
NCT05940259Recruiting
Study in Patients With Solid Tumor Regarding Access to Dermo-cosmetics and Aesthetic Solutions
Institut de cancérologie Stras... · France
NCT05907551Not yet recr...
About this profile

Access comprehensive clinical trial information for Neoplasms through Pure Global AI's free database. This collection includes 482 clinical trials across multiple phases including Phase 1, N/A, Phase 2. Currently, 54 trials are actively recruiting participants.

Research for Neoplasms is being conducted in United States of America, China, Japan and 7+ other countries. Leading sponsors include Boehringer Ingelheim and Bayer. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 482 clinical trials studying Neoplasms, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Boehringer Ingelheim, Bayer, Hoffmann-La Roche, among others.